Novo Financial Statements From 2010 to 2026

Novo Nordisk Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 562.4 B 535.7 B 179.1 B Slightly volatile Short and Long Term Debt Total 124.1 B 118.2 B 25.5 B Slightly volatile Other Current Liabilities 200.3 B 190.7 B 63.7 B Slightly volatile Total Current Liabilities 262.7 B 250.2 B 84.3 B Slightly volatile Total Stockholder Equity 173.3 B 165 B 66 B Slightly volatile Property Plant And Equipment Net 196.2 B 186.9 B 58.7 B Slightly volatile Retained Earnings 174.4 B 166.1 B 65.8 B Slightly volatile Cash 18.9 B 18 B 12.8 B Slightly volatile Non Current Assets Total 368.2 B 350.6 B 102.6 B Slightly volatile Cash And Short Term Investments 31.8 B 30.3 B 18 B Slightly volatile Net Receivables 105.6 B 100.5 B 36.8 B Slightly volatile Common Stock Shares Outstanding 4.8 B 4 B 4.9 B Slightly volatile Liabilities And Stockholders Equity 562.4 B 535.7 B 179.1 B Slightly volatile Non Current Liabilities Total 126.5 B 120.5 B 28.9 B Slightly volatile Inventory 49.3 B 47 B 18.7 B Slightly volatile Total Liabilities 389.2 B 370.7 B 113.1 B Slightly volatile Property Plant And Equipment Gross 259.5 B 247.1 B 80.7 B Slightly volatile Total Current Assets 194.3 B 185 B 76.5 B Slightly volatile Short Term Debt 15.8 B 15.1 B 4.4 B Slightly volatile Intangible Assets 109.9 B 104.7 B 27.7 B Slightly volatile Accounts Payable 34.8 B 33.2 B 11.1 B Slightly volatile Common Stock Total Equity 493.1 M 423 M 514.1 M Slightly volatile Common Stock 450.1 M 401.4 M 459.4 M Slightly volatile Other Liabilities 15.1 B 14.4 B 6.5 B Slightly volatile Property Plant Equipment 196.2 B 186.9 B 59.3 B Slightly volatile Current Deferred Revenue 129.9 B 123.7 B 52.5 B Slightly volatile Other Assets 29.7 B 28.3 B 9.1 B Slightly volatile Net Tangible Assets 37 B 36.9 B 29.2 B Slightly volatile Long Term Investments 1.6 B 3.1 B 1.4 B Slightly volatile Net Invested Capital 289.2 B 275.4 B 101.3 B Slightly volatile Capital Stock 372 M 401.4 M 467.6 M Slightly volatile
Novo Nordisk Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 10.3 B 9.8 B 5.2 B Slightly volatile Selling General Administrative 6.4 B 6.1 B 4.1 B Slightly volatile Total Revenue 350.7 B 334 B 149.3 B Slightly volatile Gross Profit 296.9 B 282.8 B 125.5 B Slightly volatile Other Operating Expenses 195.7 B 186.4 B 85.4 B Slightly volatile Operating Income 155 B 147.6 B 63.9 B Slightly volatile EBIT 155.6 B 148.2 B 63.2 B Slightly volatile EBITDA 165.9 B 158 B 68.4 B Slightly volatile Cost Of Revenue 53.8 B 51.2 B 23.8 B Slightly volatile Total Operating Expenses 141.9 B 135.2 B 61.7 B Slightly volatile Income Before Tax 153.6 B 146.3 B 62.7 B Slightly volatile Net Income 121.9 B 116.1 B 49.9 B Slightly volatile Income Tax Expense 31.6 B 30.1 B 12.9 B Slightly volatile Research Development 58 B 55.3 B 21.8 B Slightly volatile Net Income Applicable To Common Shares 121.9 B 116.1 B 45.5 B Slightly volatile Selling And Marketing Expenses 75 B 71.4 B 37.1 B Slightly volatile Net Income From Continuing Ops 121.9 B 116.1 B 45.1 B Slightly volatile Tax Provision 31.6 B 30.1 B 13.9 B Slightly volatile Interest Income 1.2 B 1.7 B 2.8 B Slightly volatile Reconciled Depreciation 23.1 B 22 B 7.5 B Slightly volatile
Novo Nordisk Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Free Cash Flow 84.1 B 80.1 B 41.4 B Slightly volatile Begin Period Cash Flow 8.6 B 16.6 B 13.1 B Slightly volatile Depreciation 10.3 B 9.8 B 5.2 B Slightly volatile Capital Expenditures 62 B 59 B 18.7 B Slightly volatile Total Cash From Operating Activities 146.1 B 139.1 B 60.2 B Slightly volatile Net Income 121.9 B 116.1 B 49.9 B Slightly volatile End Period Cash Flow 9.2 B 18 B 13.4 B Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 9.05 8.62 8.0379 Slightly volatile Dividend Yield 0.0115 0.0143 0.017 Pretty Stable PTB Ratio 18.31 17.44 16.7812 Slightly volatile Days Sales Outstanding 66.02 98.88 87.3405 Slightly volatile Book Value Per Share 30.44 28.99 14.379 Slightly volatile Free Cash Flow Yield 0.0235 0.0226 0.035 Slightly volatile Operating Cash Flow Per Share 25.67 24.44 12.0837 Slightly volatile Stock Based Compensation To Revenue 0.0044 0.0071 0.0055 Slightly volatile Capex To Depreciation 5.67 5.4 2.8394 Slightly volatile PB Ratio 18.31 17.44 16.7812 Slightly volatile EV To Sales 9.33 8.89 8.006 Slightly volatile Free Cash Flow Per Share 14.78 14.08 8.3459 Slightly volatile ROIC 0.22 0.35 0.504 Pretty Stable Inventory Turnover 1.71 1.25 1.2715 Slightly volatile Net Income Per Share 21.43 20.41 9.9901 Slightly volatile Days Of Inventory On Hand 214 301 293 Slightly volatile Payables Turnover 1.69 1.77 2.9197 Slightly volatile Sales General And Administrative To Revenue 0.0403 0.0209 0.0344 Slightly volatile Research And Ddevelopement To Revenue 0.17 0.19 0.1425 Pretty Stable Capex To Revenue 0.12 0.2 0.101 Slightly volatile Cash Per Share 5.58 5.32 3.8735 Slightly volatile POCF Ratio 14.7 20.68 20.584 Slightly volatile Interest Coverage 72.69 76.51 322 Slightly volatile Payout Ratio 0.26 0.39 0.4107 Pretty Stable Capex To Operating Cash Flow 0.53 0.49 0.2935 Pretty Stable PFCF Ratio 19.5 35.92 29.0263 Slightly volatile Days Payables Outstanding 223 213 145 Slightly volatile Income Quality 1.44 1.38 1.2603 Very volatile ROE 0.67 0.63 0.6422 Slightly volatile EV To Operating Cash Flow 14.47 21.33 20.406 Slightly volatile PE Ratio 17.42 24.78 24.4094 Slightly volatile Return On Tangible Assets 0.15 0.26 0.3082 Very volatile EV To Free Cash Flow 20.02 37.05 28.7069 Slightly volatile Earnings Yield 0.0584 0.0418 0.0475 Slightly volatile Intangibles To Total Assets 0.23 0.21 0.1009 Slightly volatile Current Ratio 0.81 0.85 1.2645 Slightly volatile Tangible Book Value Per Share 3.73 6.55 7.4516 Pretty Stable Receivables Turnover 5.3 3.82 4.3605 Slightly volatile Graham Number 121 115 56.7354 Slightly volatile Shareholders Equity Per Share 30.44 28.99 14.379 Slightly volatile Debt To Equity 0.86 0.82 0.2276 Slightly volatile Capex Per Share 10.89 10.37 3.7384 Slightly volatile Revenue Per Share 61.62 58.68 29.8827 Slightly volatile Interest Debt Per Share 22.22 21.16 5.2699 Slightly volatile Debt To Assets 0.27 0.25 0.0797 Slightly volatile Enterprise Value Over EBITDA 11.23 18.78 17.403 Slightly volatile Short Term Coverage Ratios 8.78 9.25 54.3937 Pretty Stable Price Earnings Ratio 17.42 24.78 24.4094 Slightly volatile Operating Cycle 280 400 380 Slightly volatile Price Book Value Ratio 18.31 17.44 16.7812 Slightly volatile Days Of Payables Outstanding 223 213 145 Slightly volatile Dividend Payout Ratio 0.26 0.39 0.4107 Pretty Stable Price To Operating Cash Flows Ratio 14.7 20.68 20.584 Slightly volatile Price To Free Cash Flows Ratio 19.5 35.92 29.0263 Slightly volatile Pretax Profit Margin 0.22 0.39 0.3817 Pretty Stable Ebt Per Ebit 1.2 1.14 1.0116 Pretty Stable Operating Profit Margin 0.21 0.4 0.3881 Pretty Stable Effective Tax Rate 0.3 0.24 0.2209 Pretty Stable Company Equity Multiplier 3.07 2.92 2.2943 Slightly volatile Long Term Debt To Capitalization 0.45 0.43 0.172 Slightly volatile Total Debt To Capitalization 0.5 0.48 0.1523 Slightly volatile Return On Capital Employed 0.3 0.47 0.6582 Pretty Stable Debt Equity Ratio 0.86 0.82 0.2276 Slightly volatile Ebit Per Revenue 0.21 0.4 0.3881 Pretty Stable Quick Ratio 0.6 0.63 0.9443 Slightly volatile Dividend Paid And Capex Coverage Ratio 1.26 1.14 1.6321 Slightly volatile Net Income Per E B T 0.59 0.71 0.7697 Pretty Stable Cash Ratio 0.0786 0.0828 0.3432 Slightly volatile Cash Conversion Cycle 204 187 247 Slightly volatile Operating Cash Flow Sales Ratio 0.22 0.37 0.3596 Slightly volatile Days Of Inventory Outstanding 214 301 293 Slightly volatile Days Of Sales Outstanding 66.02 98.88 87.3405 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 0.42 0.52 0.7042 Pretty Stable Cash Flow Coverage Ratios 1.01 1.06 36.4788 Slightly volatile Price To Book Ratio 18.31 17.44 16.7812 Slightly volatile Fixed Asset Turnover 1.7 1.61 2.7883 Slightly volatile Capital Expenditure Coverage Ratio 2.71 2.12 4.5729 Slightly volatile Price Cash Flow Ratio 14.7 20.68 20.584 Slightly volatile Enterprise Value Multiple 11.23 18.78 17.403 Slightly volatile Debt Ratio 0.27 0.25 0.0797 Slightly volatile Cash Flow To Debt Ratio 1.01 1.06 36.4788 Slightly volatile Price Sales Ratio 9.05 8.62 8.0379 Slightly volatile Return On Assets 0.14 0.2 0.2802 Slightly volatile Asset Turnover 0.66 0.56 0.9075 Slightly volatile Net Profit Margin 0.17 0.31 0.3011 Slightly volatile Gross Profit Margin 0.58 0.76 0.7977 Very volatile Price Fair Value 18.31 17.44 16.7812 Slightly volatile Return On Equity 0.67 0.63 0.6422 Slightly volatile
Novo Nordisk Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 644.9 B 614.2 B 616.3 B Slightly volatile Enterprise Value 632 B 601.9 B 603.8 B Slightly volatile

Novo Fundamental Market Drivers

Novo Upcoming Events

About Novo Nordisk Financial Statements

Pair Trading with Novo Nordisk

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Novo Nordisk position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will appreciate offsetting losses from the drop in the long position's value.When determining whether Novo Nordisk AS offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Novo Nordisk's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Novo Nordisk As Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Novo Nordisk As Stock:

How To Invest In Novo Details

Is Novo Stock a good investment? Details

What is Novo Nordisk's Net Worth? Details

Largest Pharmaceuticals Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details